Skip to main content
Atrás
Watch Compare

HCW Biologics Inc.

Calidad de datos: 83%
HCWB
Nasdaq Manufacturing Chemicals
$0.34
▲ $0.01 (2.77%)
Cap. Mercado: 2.27 M
Precio
$0.34
Cap. Mercado
2.27 M
Rango del Día
$0.33 — $0.35
Rango de 52 Semanas
$0.25 — $17.80
Volumen
317,275
Apertura $0.33
Promedio 50D / 200D
$0.72
53.33% below
Promedio 50D / 200D
$2.74
87.71% below

Quick Summary

Puntos Clave

Negative free cash flow of -13.39 M

Crecimiento

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
N/A
ROIC-149.86%
Net MarginN/A
Op. MarginN/A

Seguridad

Debt / Equity
N/A
Current Ratio0.06
Interest Coverage-15.58

Valoración

PE (TTM)
-0.29
Above sector avg (-1.48)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Manufacturing (1364 pares)
Métrica Acción Mediana del Sector
P/E -0.3 -1.5
P/B — 1.6
ROE % — -53.4
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -7.96 M
ROE N/A ROA -29.29%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -13.39 M
ROIC -149.86% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0.06
Interest Coverage -15.58 Asset Turnover N/A
Working Capital -25.27 M Tangible Book Value -2.11 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.29 Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -589.57%
Market Cap 2.27 M Enterprise Value 7.98 M
Per Share
EPS (Diluted TTM) -10.63 Revenue / Share N/A
FCF / Share -1.99 OCF / Share -1.99
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 168.24%
SBC-Adj. FCF -14.38 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2021 FY2022
Revenue — — — 4.10 M —
Net Income -7.96 M -30.02 M -24.99 M -12.86 M -14.90 M
EPS (Diluted) -10.63 -0.77 -0.70 — -0.42
Gross Profit 10,846.0 959,403.0 560,360.0 — 2.59 M
Operating Income -13.16 M -29.48 M -25.72 M -13.37 M -15.08 M
EBITDA — — — — —
R&D Expenses 5.44 M 6.39 M 7.68 M 8.17 M 9.34 M
SG&A Expenses — — — — —
D&A — 1.18 M 1.14 M 543,598.0 717,854.0
Interest Expense 845,051.0 631,137.0 283,042.0 — 126,660.0
Income Tax 0.0 0.0 0.0 0.0 0.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2021 FY2022
Total Assets 24.52 M 30.24 M 28.51 M 53.51 M 46.81 M
Total Liabilities 21.76 M 37.01 M 15.05 M — 9.38 M
Shareholders' Equity 2.76 M -6.77 M 13.46 M 51.19 M 37.43 M
Total Debt 6.81 M 13.69 M 6.30 M — 6.41 M
Cash & Equivalents 1.95 M 4.67 M 3.60 M 11.73 M 22.33 M
Current Assets 2.28 M 5.70 M 6.40 M 40.48 M 34.07 M
Current Liabilities 21.06 M 29.63 M 8.75 M 2.32 M 2.96 M